Phase II Study of Velcade, Decadron, and Doxil Followed by Cyclophosphamide in Multiple Myeloma

NCT00148317 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Bortezomib
DRUG: dexamethasone
DRUG: liposomal doxorubicin
DRUG: cyclophoshamide
DRUG: filgrastim

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]